November 13, 2025
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreDecember 24, 2025
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreDecember 29, 2025
The cardiometabolic diseases market size is anticipated to grow from USD 292.04 billion in 2026 to USD 1987.69...
Read MoreNovember 01, 2025
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreJanuary 15, 2026
Based on market forecasts, the dermatology sector will expand from USD 1.51 billion in 2025 to USD 2.95 billion by 2035, experiencing a CAGR of 6.94%. In 2024, Asia-Pacific led the global dermatology market, while North America is set for the fastest growth. Cosmetic dermatology dominated by product type, but surgical dermatology is expected to ris...
January 15, 2026
Projections indicate the global chemotherapy market will increase from USD 10.29 billion in 2025 to USD 21.33 billion by 2035, experiencing a CAGR of 7.56% over the next 10 years. In 2024, North America led the global chemotherapy market with a 45% share. The Asia Pacific region is expected to grow the fastest. Alkylating agents dominated, while le...
January 15, 2026
Based on market forecasts, the personalized medicine sector will expand from USD 620.14 billion in 2025 to USD 1368.89 billion by 2035, experiencing a CAGR of 8.24%. The ever-increasing personalized medicine market, due to personalized medicine, aims to make more accurate diagnoses, improve treatment outcomes, and reduce side effects by tailoring t...
January 15, 2026
According to market projections, the IV bags sector is expected to grow from USD 2.06 billion in 2025 to USD 3.74 billion by 2035, reflecting a CAGR of 6.14%. The rising geriatric population, increasing acute and chronic disorders, rising adoption of intravenous therapies, and increasing healthcare investments drive the market....
January 15, 2026
Market insights predict, the epinephrine industry is expected to grow from USD 3.37 billion in 2025 to USD 7.51 billion by 2035, driven by a CAGR of 8.34%. The increasing incidences of acute disorders like cardiovascular disorders, asthma, and allergic reactions; advanced healthcare infrastructure; and growing research & development activities ...
January 15, 2026
Market insights predict the global diabetic foot ulcer treatment industry will increase from USD 5.85 billion in 2025 to USD 10.52 billion by 2035, achieving a CAGR of 6.04%. A lot of factors contribute to the growing number of diabetic patients. One of the major factors is a sedentary lifestyle due to occupation, obesity, etc, which causes diabete...
January 14, 2026
Based on our forecasts, the behavioural mental health tools market was valued at USD 3.36 billion in 2025 and is expected to grow from USD 3.85 billion in 2026 to USD 13.28 billion by 2035, registering a CAGR of 14.74% during the forecast period....
January 14, 2026
The GLP-1 receptor agonist market size is calculated at $62.86 bn in 2025 is to hit $315.33 bn by 2035. GLP-1 receptor agonists are peptide drugs that mimic the GLP-1 hormone to lower blood glucose and aid weight loss. With rising diabetes and obesity rates, the market is growing. Recent developments include Eli Lilly's Zepbound, Novo Nordisk's par...
January 14, 2026
Based on market forecasts, the chronic obstructive pulmonary disease sector will expand from USD 23.55 billion in 2025 to USD 36.29 billion by 2035, experiencing a CAGR of 4.42%. In 2023, North America led the COPD market, with chronic bronchitis and drug treatments taking the top spots. Hospitals and clinics were the key end users. Looking ahead, ...
January 14, 2026
Projections indicate that, the global anxiety disorders treatment market will increase from USD 12.33 billion in 2025 to USD 17.56 billion by 2035, experiencing a CAGR of 3.6% over the next 10 years. Anxiety disorder treatment helps manage excessive worry and fear through therapy, medication, or lifestyle changes. Common options include cognitive b...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com